Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CCR6 | P51684 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22780788 | 0.88 | ALDH1A1 (0.50) | ALDH1A1MAPTHPGDRIPK1MAPK1 | |
| SCHEMBL23944461 | 0.85 | ALDH1A1 (0.55) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL25901621 | 0.84 | ALDH1A1 (0.53) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL23944994 | 0.83 | MBOAT4 (0.47) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL1285759 | 0.83 | ALDH1A1 (0.51) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL19139780 | 0.81 | MMP8 (0.48) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL13300890 | 0.80 | ALDH1A1 (0.49) | ALDH1A1MAPTHPGDRIPK1MAPK1 | |
| SCHEMBL13397665 | 0.80 | ALDH1A1 (0.53) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL16068200 | 0.80 | KMT2A (0.47) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL11566331 | 0.80 | ALDH1A1 (0.45) | ALDH1A1MAPTHPGDRIPK1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10736878-B2 | Treatment of organophosphate exposure with triptans | PFADENHAUER TINA (US) | 2020-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10736878-B2 | Treatment of organophosphate exposure with triptans | DDT, THOP1, TPP1 | ALDH1A1 1032/4885MAPT 3397/4885HPGD 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.